29/03/2019
M&S Decisions took part in the Annual Meeting of American Association of Cancer Research 2019 in Atlanta, US, where two works were presented:
- “Mechanistic insights and dose optimization for AZD3458, a novel selective PI3Kʏ immuno-modulator, using a quantitative systems approach”;
- “Linking tumor microenvironment properties in murine syngeneic tumors with resistance to immune checkpoint inhibitors: Insights from a quantitative systems approach”.
